Literature DB >> 2736799

The distribution of phenotypically distinct macrophage subsets in the lungs of patients with cryptogenic fibrosing alveolitis.

B Noble1, R M Du Bois, L W Poulter.   

Abstract

Monoclonal antibodies that identify phenotypically distinct macrophage subsets were used to analyse the macrophages in lung biopsy specimens and bronchoalveolar lavage fluid from patients with cryptogenic fibrosing alveolitis. Among the antibodies were RFD1, an interdigitating cell marker, RFD7, a marker for mature tissue macrophages, and RFD9, which identifies epithelioid cells as well as germinal centre macrophages. The lavage fluid was found to contain abnormally high numbers of cells staining with each of the antibodies, a finding that could be explained, at least in part, by an increased frequency of cells expressing more than one marker. In lung tissue macrophage phenotypes within the interstitium were found to differ significantly from those in the alveolar space. Most strikingly, cells bearing the antigen recognized by RFD9 were entirely absent from the interstitial macrophage population, whereas the vast majority in the alveolar lumen were RFD9-positive. The discrete compartmentalization of phenotypically different macrophages within the lung suggests that macrophages may contribute differently to lung pathology in each microenvironment. The functional capacity of the unusual RFD9-positive alveolar macrophages remains to be determined, but their close association with the process of alveolar occlusion indicates a role in the fibrotic process.

Entities:  

Mesh:

Year:  1989        PMID: 2736799      PMCID: PMC1541733     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Lymphocyte phenotypes in bronchoalveolar lavage and lung tissue in sarcoidosis and idiopathic pulmonary fibrosis.

Authors:  I L Paradis; J H Dauber; B S Rabin
Journal:  Am Rev Respir Dis       Date:  1986-05

2.  Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity.

Authors:  D A Campbell; L W Poulter; G Janossy; R M du Bois
Journal:  Thorax       Date:  1985-06       Impact factor: 9.139

3.  Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features.

Authors:  P L Haslam; C W Turton; B Heard; A Lukoszek; J V Collins; A J Salsbury; M Turner-Warwick
Journal:  Thorax       Date:  1980-01       Impact factor: 9.139

4.  Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.

Authors:  G W Hunninghake; J E Gadek; T J Lawley; R G Crystal
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

5.  Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders.

Authors:  P B Bitterman; S Adelberg; R G Crystal
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

6.  Intraluminal fibrosis in interstitial lung disorders.

Authors:  F Basset; V J Ferrans; P Soler; T Takemura; Y Fukuda; R G Crystal
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

7.  Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases.

Authors:  B Wallaert; F Bart; C Aerts; A Ouaissi; P Y Hatron; A B Tonnel; C Voisin
Journal:  Thorax       Date:  1988-01       Impact factor: 9.139

8.  Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases.

Authors:  S I Rennard; G W Hunninghake; P B Bitterman; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

9.  Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.

Authors:  A J Hance; S Douches; R J Winchester; V J Ferrans; R G Crystal
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

10.  Immunocompetent cells in bronchoalveolar lavage reflect the cell populations in transbronchial biopsies in pulmonary sarcoidosis.

Authors:  D A Campbell; L W Poulter; R M du Bois
Journal:  Am Rev Respir Dis       Date:  1985-12
View more
  6 in total

1.  Phenotypic markers of alveolar macrophage maturation in pulmonary sarcoidosis.

Authors:  I Stríz; Y M Wang; H Teschler; C Sorg; U Costabel
Journal:  Lung       Date:  1993       Impact factor: 2.584

2.  Differences in expression of monocyte/macrophage surface antigens in peripheral blood and bronchoalveolar lavage cells in interstitial lung diseases.

Authors:  H C Hoogsteden; P T van Hal; J M Wijkhuijs; W Hop; C Hilvering
Journal:  Lung       Date:  1993       Impact factor: 2.584

3.  Changes to alveolar macrophage phenotype in HIV infected individuals with normal CD4 counts and no respiratory disease.

Authors:  M C Lipman; M A Johnson; D H Bray; L H Poulter
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

4.  Changes in phenotypically distinct mucosal macrophage populations may be a prerequisite for the development of inflammatory bowel disease.

Authors:  M C Allison; L W Poulter
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

5.  Antiretroviral treatment reverses HIV-induced reduction in the expression of surface antigens on alveolar macrophages in AIDS patients.

Authors:  D H Bray; S B Squire; A Kawana; M A Johnson; L W Poulter
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

Review 6.  Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung.

Authors:  B E Lehnert
Journal:  Environ Health Perspect       Date:  1992-07       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.